References for this Review were selected by a PubMed search of English language publications and covered the period from 1946 to November, 2008, by use of the terms “Behçet's”, “Behçet's disease”, “Behçet's syndrome”, and “neuro-Behçet's”. Further articles were identified from the references cited in those articles. Abstracts were reviewed, and when relevant findings were reported, the full article was retrieved and reviewed. We also identified articles from our personal knowledge of the
ReviewNeuro-Behçet's disease: epidemiology, clinical characteristics, and management
Introduction
Behçet's disease (BD) bears the name of a Turkish dermatologist, Hulusi Behçet, who described the triad of recurrent oral and genital ulcers and uveitis in 1937.1 BD is a multisystem disease of unknown cause in which an inflammatory perivasculitis can arise in almost any tissue.2, 3 The highest incidence of BD is in the Middle East, the Mediterranean basin, and the Far East regions, but it is rare in Europe and North America. The nature and prevalence of the various systemic features are summarised in table 1.4 The most widely accepted criteria for the diagnosis of BD are the International BD Study Group criteria (panel 1).5
Neurological involvement is one of the most serious causes of long-term morbidity and mortality in BD.6 Although BD is rare in neurological practice in most countries, it is commonly mentioned in the differential diagnosis of inflammatory or demyelinating CNS diseases. In this Review, we summarise and describe the current understanding of the various neurological aspects of BD with a special emphasis on practical aspects of the diagnosis and management of neurological complications.
Section snippets
Epidemiology
Over the past 15 years, increasing numbers of patients have been reported in different series that have described the various clinical and epidemiological features of neuro-BD (NBD). Table 2 summarises the findings of these reports.7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
The frequency of neurological involvement in BD is very variable; in hospital-based series, percentages as low as 1·3%26 and as high as 59%10 have been reported, but are likely to be biased for
Classification
The CNS is the major target of neurological involvement in BD. There are two categories of CNS involvement in BD that have been generally accepted (panel 2): parenchymal and non-parenchymal involvement.8, 11, 12, 13, 14, 19, 22, 25, 34, 35, 36 In the parenchymal category, meningoencephalitis occurs, whereas in non-parenchymal NBD, vascular complications involving thrombosis within large veins and occasionally arteries occur. Involvement of parenchymal tissue either does not occur in
Neuropathology
The neuropathology of parenchymal NBD in the acute phase involves meningoencephalitis with an intense inflammatory infiltration including polymorphs, eosinophils, lymphocytes, and macrophages, with areas of necrosis and apoptotic neuronal loss.37 Intense inflammatory infiltration of small vessels can occur, but fibrinoid necrosis is not seen. NBD is therefore not a cerebral vasculitis (as blood vessel walls are not infiltrated and there is no evidence for endothelial cell necrosis); rather, it
Diagnosis
The diagnosis of neurological involvement in BD is done mainly by clinical means; the ancillary investigations noted below help to suggest alternatives, and especially infective complications of treatment, but there is no diagnostic test for NBD. In a patient with a clinical syndrome characteristic of systemic BD, with, for example, retinal vasculitis, orogenital ulceration, pathergy, and joint involvement, the presence of a sagittal venous sinus thrombosis or an inflammatory brainstem lesion
Parenchymal NBD
Subacute meningoencephalitis accounts for 75% of cases in parenchymal NBD (table 2). Onset is commonly subacute,11, 12, 13 and often associated with exacerbation of the systemic features of BD, including fever, malaise, orogenital ulcers, skin lesions, or uveitis.11, 19, 24, 60 Headache is common before and during the attack. The symptoms and signs take a few days to reach a peak and last for several weeks, depending on the extent of the lesion and on how rapidly treatment is initiated. Less
Management
There have been no controlled or comparative trials of treatment of any aspect of neurological involvement in BD. There is a consensus among neurologists with experience in the management of these disorders that, in most cases of inflammatory parenchymal disease, corticosteroids should be given as infusions of intravenous methylprednisolone followed by a slowly tapering course of oral steroids. It is important to avoid an abrupt cessation of therapy to avoid early relapse. Whether
Clinical course and prognosis
Most patients who have an acute parenchymal inflammatory episode recover well after steroid treatment. Retrospective series from 10–15 years ago reported a mean of 20–30% of patients with residual neurological impairments,12, 14 and a high 10-year mortality of 10%. Around a third of patients have single episodes, a third have repeated relapses with remission, and a third undergo a progressive disease course with accrual of neurological impairments.11, 12, 13, 14 A primarily progressive disease
Conclusions and further perspectives
Over the past 10 years, our understanding of the clinical features and pathophysiology of neurological complications in BD has increased substantially due to the simultaneous interest of clinical researchers around the world. We have reviewed the current understanding of the nature, pathogenesis, and management of NBD. Parenchymal complications arise due to a meningoencephalitis that might occur in the brainstem, cerebral hemispheres, spinal cord, or cranial nerves. Diffuse and progressive
Search strategy and selection criteria
References (150)
- et al.
Neuro-Behçet's disease in Iraq: a study of 40 patients
J Neurol Sci
(1999) - et al.
MRI findings in neuro-Behçet's disease
Clin Radiol
(2001) - et al.
Neuro-Behçet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behçet's disease in 96 Iranian patients
Exp Mol Pathol
(2003) - et al.
Demographic and clinical properties of juvenile-onset Behçet's disease: a controlled multicenter study
J Am Acad Dermatol
(2008) Histopathology of central nervous system lesions in Behçet's disease
J Neurol Sci
(2008)- et al.
Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases
J Neuroimmunol
(2003) - et al.
Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet's syndrome
Clin Immunol Immunopathol
(1997) - et al.
Neurologic aspects of Behçet's disease. Case report and review of the literature
Am J Med
(1963) - et al.
Effect of infliximab in progressive neuro-Behçet's syndrome
J Neurol Sci
(2008) - et al.
Epilepsia partialis continua in a patient with Behçet's disease
Clin Neurol Neurosurg
(2006)
Neuro-Behçet's disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review
J Neurol Sci
Optic nerve involvement in neuro-Behçet's disease
Jpn J Ophthalmol
Über residivierende, aphtöse durch ein Virus verursachtes Geschwüre am Mund, am Auge und an der Genitalien
Derm Wschr
Behçet's disease
N Engl J Med
Behçet's disease: from Hippocrates to the third millennium
Br J Ophthalmol
Behçet's syndrome: disease manifestations, management, and advances in treatment
Nat Clin Pract Rheumatol
Criteria for diagnosis of Behçet's disease
Lancet
The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center
Medicine (Baltimore)
Clinical and biological aspects of neuro-Behçet's in Tunisia
Neuro-Behçet's: clinical syndromes and prognosis
Magnetic resonance imaging and brain-stem auditory evoked potentials in neuro-Behçet's disease
J Neurol
Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations
J Neurol Neurosurg Psychiatry
Neurological complications of Behçet's syndrome
Brain
Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group
Brain
Behçet's disease: diagnostic and prognostic aspects of neurological involvement
J Neurol
The clinical involvement patterns of neuro-Behçet's disease
Eur J Neurol
Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings
J Neurol
Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up
Adv Exp Med Biol
Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq
J Neurol Neurosurg Psychiatry
Visual evoked potentials in differential diagnosis of multiple sclerosis and neurobehçet's disease
Tohoku J Exp Med
Neurological manifestations of Behçet's disease
Saudi Med J
Neurological involvement in North Italian patients with Behçet disease
Rheumatol Int
Clinical characterization and pattern of neurological involvement of Behçet's disease in fifteen Portuguese patients
Clin Exp Rheumatol
Neuro-Behçet's disease in caucasians: a study of 22 patients
Eur J Neurol
Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients
Clin Exp Rheumatol
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease
Int J Dermatol
Neurological involvement in Behçet's syndrome—a prospective study
Arch Neurol
Childhood Behçet's disease: clinical features and comparison with adult-onset disease
Rheumatology (Oxford)
Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany
Dermatology
MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation
J Neurol Neurosurg Psychiatry
Ocular and neurological Behçet's disease without orogenital ulceration?
J Neurol Neurosurg Psychiatry
MRI findings in neuro-Behçet's disease
Neurology
Behçet's disease and the nervous system
J Neurol
Neuro-Behçet disease. A review
Neurologist
Neuro-Behçet's disease
Clin Neuropathol
Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation
Neuropathology
Behçet's disease with cerebral vasculitis
Int Med J
CNS involvement in neuro-Behçet syndrome: an MR study
Am J Neuroradiol
Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature
Neuroradiology
Behçet's diseases with multiple intracranial arterial aneurysms
Rev Neurol (Paris)
Cited by (374)
Therapeutic approach to central nervous system involvement of Behçet's disease
2023, Seminars in Arthritis and RheumatismMyelin basic protein and index for neuro-Behçet's disease
2023, Clinical ImmunologyPeripheral neuropathies during systemic diseases: Part II (vasculitis)
2023, Revue de Medecine InterneThe Role of Colchicine in Different Clinical Phenotypes of Behcet Disease
2023, Clinical TherapeuticsIt Looks Like a Spinal Cord Tumor but It Is Not
2024, CancersBehçet’s syndrome
2024, New England Journal of Medicine